- Biomarkers for Colorectal Cancer Treatment
-
Suk KT, Kim HS
- KMID: 1062808
- Korean J Gastroenterol.
- 2009 Feb;53(2):68-75.
Individualized tailored therapy is a currently pursuing direction for improving the outcome of patients with colorectal cancer. Targeted therapy is the potential strategy to reach this goal by evaluating status... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy for Colorectal Cancer
-
Hong YS, Kim TW
- KMID: 1775934
- Korean J Gastroenterol.
- 2009 Dec;54(6):355-363.
- doi: 10.4166/kjg.2009.54.6.355
Recent advances in chemotherapy lead to improved survival outcomes in patients with colorectal cancer. The 5-fluorouracil (5-FU) is still one of the important chemotherapeutic agents since 1950s, but the introduction... -
- CITED
-
- Close
- SHARE
-
- Close
- Heterogeneity of Adenosine Triphosphate-Based Chemotherapy Response Assay in Colorectal Cancer - Secondary Publication
-
Huh JW, Park YA, Lee KY, Sohn SK
- KMID: 1103825
- Yonsei Med J.
- 2009 Oct;50(5):697-703.
- doi: 10.3349/ymj.2009.50.5.697
PURPOSE: Adenosine triphosphate-based chemotherapy response assay (ATP-CRA) is a well-documented and validated technology that can individualize chemotherapy for patients with lung, stomach, or breast cancer. This study explored the feasibility... -
- CITED
-
- Close
- SHARE
-
- Close
- Irinotecan, Continuous 5-Fluorouracil, and Low dose of Leucovorin (modified FOLFIRI) as First Line of Therapy in Recurrent or Metastatic Colorectal Cancer
-
Lee MA, Byun JH, Shim BY, Woo IS, Kang JH, Hong YS, Lee KS, Choi MG, Chang SK, Oh ST, Choi SI, Lee DS
- KMID: 1782231
- Korean J Intern Med.
- 2005 Sep;20(3):205-209.
- doi: 10.3904/kjim.2005.20.3.205
BACKGROUND: Irinotecan, in combination with 5-fluorouracil (5-FU) and a high dose of leucovorin (LV), known as FOLFIRI regimen, has shown activity in recurrent or metastatic colorectal cancer. Therefore, we evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Therapy-Related Acute Myeloid Leukemia Following 5-Fluorouracil Chemotherapy
-
Park HJ, Choi JH, Lee KA, Kim HC, Nam YS, Oh YH, Lee WS
- KMID: 1776578
- Korean J Intern Med.
- 2012 Mar;27(1):115-117.
- doi: 10.3904/kjim.2012.27.1.115
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- FOLFIRI as Second-line Chemotherapy after Failure of FOLFOX4 in Advanced Colorectal Cancer: A Korean Single-center Experience
-
Kim JH, Park SJ, Park MI, Moon W, Kim SE, Ku KH, Song SE, Kim JH
- KMID: 1711301
- Korean J Gastroenterol.
- 2014 Jan;63(1):18-24.
- doi: 10.4166/kjg.2014.63.1.18
BACKGROUND/AIMS: The incidence of colorectal cancer has been increasing every year in Korea. Irinotecan- or oxaliplatin-based regimens including biologic agents are known to be effective in patients with advanced colorectal... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study of Cetuximab (Erbitux(R)) plus FOLFIRI for Irinotecan and Oxaliplatin-refractory Metastatic Colorectal Cancer
-
Koo DH, Lee JL, Kim TW, Chang HM, Ryu MH, Lee SS, Kim MK, Sym SJ, Lee JS, Kang YK
- KMID: 1785796
- J Korean Med Sci.
- 2007 Sep;22(Suppl):S98-S103.
- doi: 10.3346/jkms.2007.22.S.S98
We have evaluated the efficacy and safety of cetuximab plus FOLFIRI for irinotecan and oxaliplatin-refractory colorectal cancers. From September 2004 to February 2006, 31 patients with metastatic colorectal cancer were... -
- CITED
-
- Close
- SHARE
-
- Close
- Reduced Dose Intensity FOLFOX-4 as First Line Palliative Chemotherapy in Elderly Patients with Advanced Colorectal Cancer
-
Kim JH, Oh DY, Kim YJ, Han SW, Choi IS, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK
- KMID: 1781763
- J Korean Med Sci.
- 2005 Oct;20(5):806-810.
- doi: 10.3346/jkms.2005.20.5.806
To evaluate the toxicity and efficacy of a reduced dose intensity (mini-) FOLFOX-4 regimen as a first-line palliative chemotherapy in elderly patients (> or =70 yr of age) with advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Outpatient-basis Chemotherapy of Oxaliplatin, 5-fluorouracil, and Leucovorin as First-line Treatment for Patients with Metastatic or Recurrent Colorectal Cancer
-
Moon JH, Kim JG, Sohn SK, Baek JH, Cho YY, Chae YS, Ahn BM, Kim SN, Lee SJ, Lee IT, Choi GS, Jun SH
- KMID: 1778344
- J Korean Med Sci.
- 2007 Jun;22(3):400-404.
- doi: 10.3346/jkms.2007.22.3.400
The objectives of the present study were to evaluate the efficacy and safety of an outpatient-basis chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin as the first-line treatment for patients with advanced... -
- CITED
-
- Close
- SHARE
-
- Close
